Alcon will expand its femtosecond laser-assisted cataract surgery offerings with a deal to acquire Lensar, according to a ...

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser ...

Medically reviewed by Christine L. Larsen, MD A cataract (cloudy eye lens) blocks light from reaching the retina, which helps ...

Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary ...

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser ...

Alcon announced today that it entered into a definitive merger agreement through which it intends to acquire Lensar.

Alcon (ALC) and LENSAR (LNSR) have entered into a definitive merger agreement through which Alcon intends to acquire LENSAR. The acquisition ...

From persistent dry eyes to unexpected complications – what experts say you should know before undergoing Lasik surgery.

Alcon has agreed to acquire the medical-technology company Lensar in a deal that could be worth up to $430 million. The eye-care company said Monday that it would pay $14 for each Lensar share in cash ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology ...

Cataracts can be treated with surgery, and wet AMD can be treated with medications and laser therapies. However, the most common form of macular degeneration, dry AMD, causes permanent vision loss.